Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis

Overview of attention for article published in European Heart Journal, May 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 3 news outlets
twitter: 88 X users
reddit: 1 Redditor

guideline: 1 clinical guideline source
bluesky: 13 Bluesky users

Readers on

mendeley: 103 Mendeley

So far, Altmetric has seen 18 Bluesky posts from 13 Bluesky users, with an upper bound of 24,770 followers.

The results of this study is the equivalent of taking antacids for a runny nose and being surprised it had no significant impact on your nose. A bit misleading, don't you think? Colchicine works, just not on respiratory issues. academic.oup.com/eurhear…

RP @nwamacman.bsky.social: COLCHICINE: 2025 meta-analysis in secondary prevention #Cardiosky academic.oup.com/eurheartj/ar...

COLCHICINE: 2025 meta-analysis in secondary prevention #Cardiosky academic.oup.com/eurheartj/ar...

"Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis." Publié en juillet dans Eur Heart J. #MedSky #CardioSky academic.oup.com/eurheartj/ar...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 14 additional Bluesky posts.